Trial Profile
Investigator Sponsored Trial of Polypoidal Choroidal Vasculopathy (PCV) Evaluation Assessing High-Dose Ranibizumab Prospectively.
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 14 Sep 2017
Price :
$35
*
At a glance
- Drugs Ranibizumab (Primary)
- Indications Polypoidal choroidal vasculopathy
- Focus Therapeutic Use
- 28 May 2015 New trial record